Today, Penumbra announced the CE Mark and European launch of BMX\u212281 and BMX\u212296. These devices are designed for neurovascular management of ischemic and hemorrhagic stroke and are Penumbra\u2019s most advanced neuro access offerings.<\/p>\n
This announcement further expands the company\u2019s neuro portfolio in Europe, following the news in early May when Penumbra launched three new RED\u2122 reperfusion catheters (RED 43, RED 72 with SENDit\u2122 Technology, and RED 78).<\/p>\n
\u201cPhysicians in Europe now have more options to serve their patients using our expanded portfolio. With five innovative devices introduced in Europe in a matter of months, our dedication to improving stroke care enables us to provide physicians with customised stroke solutions,\u201d said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra, Inc. \u201cIn all modesty, Penumbra provides physicians with the widest aspiration thrombectomy stroke portfolio on the market.\u201d<\/p>\n
Unlike traditional access catheters, Penumbra\u2019s BMX81 and BMX96 are made using laser-cut stainless steel hypotube technology, offering stability and trackability. They are designed to allow physicians to easily navigate the brain\u2019s complex anatomy and can be used from either a femoral or radial access approach (i.e. via groin or wrist). The stainless steel hypotube also allows for a larger inner diameter while maintaining a lower outer diameter without compromising support. This expands intraprocedural options in both ischemic and hemorrhagic stroke.<\/p>\n
\u201cI need to be able to trust that my access catheters can provide the stability that I need. The new BMX catheters promise excellent support. With their expanded inner diameters, I will be able to increase therapeutic options for my patients, especially when going radial,\u201d said Dr. Markus Holtmannsp\u00f6tter, Head of Neuroradiology at Klinikum N\u00fcrnberg, Germany.<\/p>\n
With 20 years of experience optimizing Science-Based Aspiration Thrombectomy (S-BAT), Penumbra\u2019s catheters are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions and to navigate the challenging vasculature of the brain.<\/p>\n
In Europe, stroke is a leading cause of death and adult disability affecting approx. 1.1 million people every year and causing 440,000 deaths1<\/sup>. With the latest CE marked devices, Penumbra continues to offer the most expansive aspiration thrombectomy stroke portfolio on the market, now supported with the most advanced neuro access technologies available.<\/p>\n Important Safety Information<\/strong> 1. Cardiovascular Disease Statistics 2023, Eurostat, https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_diseases<\/a> Today, Penumbra announced the CE Mark and European launch of BMX\u212281 and BMX\u212296. These devices are designed for neurovascular management…<\/p>\n","protected":false},"author":8,"featured_media":71630,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[250,334,404],"tags":[],"class_list":["post-75525","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-eu","category-health-eu","category-health-eu-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts\/75525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/comments?post=75525"}],"version-history":[{"count":0,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/posts\/75525\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/media\/71630"}],"wp:attachment":[{"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/media?parent=75525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/categories?post=75525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.penumbrainc.com\/eu\/wp-json\/wp\/v2\/tags?post=75525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nAdditional information about Penumbra\u2019s products can be located on Penumbra\u2019s website at www.penumbrainc.com\/eu\/products\/neuro-access-catheters<\/a>. Product availability varies by country. Caution: Federal (USA) law restricts these devices to sale by or on the order of a physician. Prior to use, please refer to Instructions for Use for complete product indications, contraindications, warnings, precautions, potential adverse events and detailed instructions for use. Risk information can be found at peninc.info\/risk.<\/a><\/p>\n
\nBurden of Stroke in Europe, https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7382540\/#R1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"